Skip to content
healthcare.dev

RANOLAZINE

NDC 77771-423, RANOLAZINE, tablet, film coated, extended release, from Radha Pharmaceuticals, Inc.

Product NDC
77771-423
Status
Listed
Labeler
Radha Pharmaceuticals, Inc
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211829
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/77771-423 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
77771-423-607777104236060 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (77771-423-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/38d2833d-44b8-8d46-e063-6394a90a74d8

Use it

Look up 77771-423 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/77771-423 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 77771-423. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.